Metronomic combination chemotherapy using everolimus and etoposide for the treatment of non‐Hodgkin lymphoma

Patients with Non‐Hodgkin lymphoma (NHL) treated by conventional chemotherapeutic drugs usually require a long recovery period. However, metronomic combination chemotherapy (MCC) enhances therapeutic efficacy and decreases side effects in the treatment of NHL. In this study, we tested and compared t...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Ke, Sun, Xiao‐Qing, Wang, Cai‐Qin, Gao, Tian‐Xiao, Sun, Peng, Wang, Yu, Jiang, Wen‐Qi, Li, Zhi‐Ming, Huang, Jia‐Jia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6712471/
https://www.ncbi.nlm.nih.gov/pubmed/31218841
http://dx.doi.org/10.1002/cam4.2364

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6712471/
https://www.ncbi.nlm.nih.gov/pubmed/31218841
http://dx.doi.org/10.1002/cam4.2364

Ejemplares similares